IMCS
Integrated Micro-Chromatography Systems, Inc (IMCS) is a biotechnology company focused on delivering tools and services to...
Integrated Micro-Chromatography Systems, Inc. (IMCS) co-founders Qian Wang, Ph.D., and L. Andrew Lee, Ph.D., were both honored in Columbia Business Monthly‘s list of The 50 Most Influential People in Columbia in 2020. From the article: This biotechnology company delivers tools and services that pave the way for the future of precision medicine. The company strives …
Learn how you could simplify urine drug testing and sample preparation by combining β-Gone™ Plus β-Glucuronidase Removal and IMCSzyme® RT. We collaborated with Phenomenex to come up with an integrated urine drug testing and sample preparation workflow that will help you: Bypass the need for extra plastic consumables and additional transfer steps that could lead …
What are the advantages of incorporating Protein A IMCStips® with INTEGRA’s pipetting robots? High reproducibility with error-free pipetting Reduced hands-on time and unmatched ergonomics Dispersive solid phase extraction (dSPE) pipette tips facilitate maximum contact between resin and analyte leading to higher recoveries in less time The results shown in this application note demonstrate the consistent …
On Friday, March 20th, as the Coronavirus (COVID-19) became a worldwide threat to all nations, Pamela Quizon, PhD., one of our team of scientists, presented the idea of manufacturing hand sanitizer at IMCS based on FDA guidance. As a way to help the local healthcare community battle the COVID-19 epidemic, IMCS Chief Scientific Officer L. …
IMCS (Integrated Micro-Chromatography Systems, Inc.) is closely monitoring all Coronavirus (COVID-19) information by tracking guidance from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We understand the impact and importance of keeping a continuous supply chain in the toxicology/drug testing and biopharma industries. Our company maintains ISO 9001:2015 …
The Multi-Attribute Method (MAM) is an application of ultrahigh-performance liquid chromatography coupled to mass spectrometry (UHPLC-MS) for simultaneous detection, identification, quantitation, and monitoring of molecular attributes of biotherapeutics. Critical Quality Attributes (CQAs) are identified based on the severity of harm to patient, which include efficacy (potency), pharmacokinetics, and safety/immunogenicity. MAM is a single MS-based method …
